Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean Follmann

Showing results (51-60 of 148) with videos related to

Pageof 15
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
Reply to Phillips, Morris, and WalkerScott Evans, Dean Follmann, David Schoenfeld, et al.
Critical Care Medicine|March 18, 2022
Preintubation Sequential Organ Failure Assessment Score for Predicting COVID-19 Mortality: External Validation Using Electronic Health Record From 86 U.S. Healthcare Systems to Appraise Current Ventilator Triage AlgorithmsMichael B Keller, Jing Wang, Martha Nason, et al.
Blood|August 1, 2002
Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemiaElaine Sloand, Sonnie Kim, Jaroslaw P Maciejewski, et al.
British Journal of Haematology|October 3, 2002
Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndromeJ Joseph Melenhorst, Rhoda Eniafe, Dean Follmann, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2006
Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshopDean Follmann, Ann Duerr, Stephen Tabet, et al.
Plos One|August 5, 2016
Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the EvidenceJairo M Montezuma-Rusca, John H Powers, Dean Follmann, et al.
The New England Journal of Medicine|December 12, 2022
A Covid-19 Milestone Attained - A Correlate of Protection for VaccinesPeter B Gilbert, Ruben O Donis, Richard A Koup, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|April 15, 2003
T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57J Joseph Melenhorst, Rhoda Eniafe, Dean Follmann, et al.
Open Forum Infectious Diseases|July 14, 2023
Early Discontinuation of Antibiotics in Patients Admitted With Clinically Suspected Serious Infection but Negative Cultures: Retrospective Cohort Study of Practice Patterns and Outcomes at 111 US HospitalsSameer S Kadri, Sarah Warner, Chanu Rhee, et al.
Vaccine|March 8, 2024
Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trialPeter B Gilbert, Youyi Fong, Nima S Hejazi, et al.
Pageof 15

Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
Reply to Phillips, Morris, and WalkerScott Evans, Dean Follmann, David Schoenfeld, et al.
Critical Care Medicine|March 18, 2022
Preintubation Sequential Organ Failure Assessment Score for Predicting COVID-19 Mortality: External Validation Using Electronic Health Record From 86 U.S. Healthcare Systems to Appraise Current Ventilator Triage AlgorithmsMichael B Keller, Jing Wang, Martha Nason, et al.
Blood|August 1, 2002
Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemiaElaine Sloand, Sonnie Kim, Jaroslaw P Maciejewski, et al.
British Journal of Haematology|October 3, 2002
Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndromeJ Joseph Melenhorst, Rhoda Eniafe, Dean Follmann, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2006
Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshopDean Follmann, Ann Duerr, Stephen Tabet, et al.
Plos One|August 5, 2016
Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the EvidenceJairo M Montezuma-Rusca, John H Powers, Dean Follmann, et al.
The New England Journal of Medicine|December 12, 2022
A Covid-19 Milestone Attained - A Correlate of Protection for VaccinesPeter B Gilbert, Ruben O Donis, Richard A Koup, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|April 15, 2003
T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57J Joseph Melenhorst, Rhoda Eniafe, Dean Follmann, et al.
Open Forum Infectious Diseases|July 14, 2023
Early Discontinuation of Antibiotics in Patients Admitted With Clinically Suspected Serious Infection but Negative Cultures: Retrospective Cohort Study of Practice Patterns and Outcomes at 111 US HospitalsSameer S Kadri, Sarah Warner, Chanu Rhee, et al.
Vaccine|March 8, 2024
Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trialPeter B Gilbert, Youyi Fong, Nima S Hejazi, et al.
Pageof 15